Members
First name: Clément Last name: Massonnaud Function: Assistant hospitalo-universitaire Position: PhD student Email: clement.massonnaud inserm.fr |
Research interest
I have a keen interest in the design and methodology of clinical trials, particularly in the field of emerging infectious diseases.
My current research is centered around innovative clinical trial designs, such as adaptive platform clinical trials, and how they can effectively address the challenges posed by emerging infectious diseases for the generation of accurate and compelling scientific evidence.
My goal is to make a meaningful contribution to the improvement of public health decision-making by leveraging cutting-edge, efficient, and robust clinical trial designs and statistical methods.
Education
Degree
2022 – present: PhD student in biostatistics
2021 – MD – Specialization in Public Health, Rouen University, France
2019 – MSc Public Health – Specialization in biostatistics, EHESP, France
2021 – MD – Specialization in Public Health, Rouen University, France
2019 – MSc Public Health – Specialization in biostatistics, EHESP, France
Academic positions
2021-present: Methodologist, teaching assistant in biostatistics, Epidemiology, Biostatistics, and Clinical Research department, APHP.Nord – Université Paris Cité.
List of the main publications
Exhaustive list of publications
2024
Hites M, Lapique EL, Massonnaud CR, Belhadi D, Jamard S, Goehringer F, Danion F, Reignier J, de Castro N, Garot D, Lacombe K, Tolsma V, Faure E, Malvy D, Staub T, Courjon J, Cazenave-Roblot F, Dyrhol Riise AM, Leturnier P, Martin-Blondel G, Roger C, Akinosoglou K, Moing VL, Piroth L, Sellier P, Lescure X, Trøseid M, Clevenbergh P, Dalgard O, Gallien S, Gousseff M, Loubet P, Vardon-Bounes F, Visée C, Belkhir L, Botelho-Nevers É, Cabié A, Kotanidou A, Lanternier F, Rouveix-Nordon E, Silva S, Thiery G, Poignard P, Carcelain G, Diallo A, Mercier N, Terzic V, Bouscambert-Duchamp M, Gaymard A, Trabaud MA, Destras G, Josset L, Billard N, Han THL, Guedj J, Couffin-Cadiergues S, Dechanet A, Delmas C, Esperou H, Fougerou-Leurent C, Mestre SL, Métois A, Noret M, Bally I, Dergan-Dylon S, Tubiana S, Kalif O, Bergaud N, Leveau B, Eustace J, Greil R, Hajdu E, Halanova M, Paiva JA, Piekarska A, Rodriguez Baño J, Tonby K, Trojánek M, Tsiodras S, Unal S, Burdet C, Costagliola D, Yazdanpanah Y, Peiffer-Smadja N, Mentré F, Ader F, DisCoVeRy study group
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.
The Journal of Infection 2024, 88, 106120.
Haviari S, Massonnaud CR, Dupont A
Recombinant Influenza Vaccine in Adults under 65 Years of Age.
The New England Journal of Medicine 2024, 390, 1155.